A Study of Risk Factors for the COVID-19 Virus Infection

Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04697927
Collaborator
(none)
10,000
7
23
1428.6
62

Study Details

Study Description

Brief Summary

The purpose of this study is to collect information that will help the reasearchers learn more about COVID-19 infections in cancer patients, and to find out about the effects of these infections on cancer treatment and outcomes. The research study involves asking people to complete a series of online questionnaires that include questions about their medical history, lifestyle, and risk factors related to the COVID-19 infection. The study will enroll both MSK patients and their household family members.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaires

Study Design

Study Type:
Observational
Anticipated Enrollment :
10000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Ascertainment of Epidemiologic Risk Information to Assess Susceptibility to and Severity of SARS-CoV-2 Infection
Actual Study Start Date :
Dec 30, 2020
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
MSK Patients

Patients include those undergoing cancer screening and treatment as well as cancer survivors that received COVID-related care. Both adult and pediatric patients will be included.

Other: Questionnaires
The epidemiologic questionnaires used in this study are a composite of validated questions from multiple sources. Many of the questions are an expansion of the MSK General Medical Health clinical questionnaire. Validated questions capturing demographics, employment, risk behaviors, family history, as well as, specific research domains including psychosocial, food security, and financial toxicity have already been utilized in other MSK minimal risk studies. The COVID-19 symptom and history tracker questions were largely drawn from the COronavirus Pandemic Epidemiology (COPE) consortium study.

Household Members (identified by MSK Patient)

Individuals over the age of 18 (i.e., individuals currently living in the same household as the MSK enrollee).

Other: Questionnaires
The epidemiologic questionnaires used in this study are a composite of validated questions from multiple sources. Many of the questions are an expansion of the MSK General Medical Health clinical questionnaire. Validated questions capturing demographics, employment, risk behaviors, family history, as well as, specific research domains including psychosocial, food security, and financial toxicity have already been utilized in other MSK minimal risk studies. The COVID-19 symptom and history tracker questions were largely drawn from the COronavirus Pandemic Epidemiology (COPE) consortium study.

Outcome Measures

Primary Outcome Measures

  1. develop a comprehensive registry database [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:

MSK Patients

  • All individuals who have had at least one point of contact since January 1st 2019 as a patient, including visiting an MSK facility for treatment, clinical evaluation, follow-up or screening, COVID-related screening, or a telehealth visit. Household Members of MSK Patients

  • Individuals aged 18 or older

  • Currently reside in the same household of MSK patients enrolled onto this protocol

  • Have an email account

Exclusion Criteria:
  • Impaired decision-making capacity as noted in EHR

  • Current MSK employee

Contacts and Locations

Locations

Site City State Country Postal Code
1 Memoral Sloan Kettering Basking Ridge Basking Ridge New Jersey United States 07920
2 Memorial Sloan Kettering Monmouth Middletown New Jersey United States 07748
3 Memorial Sloan Kettering Bergen Montvale New Jersey United States 07645
4 Memorial Sloan Kettering Commack Commack New York United States 11725
5 Memorial Sloan Kettering Westchester Harrison New York United States 10604
6 Memorial Sloan Kettering Cancer Center New York New York United States 10065
7 Memorial Sloan Kettering Nassau Rockville Centre New York United States 11553

Sponsors and Collaborators

  • Memorial Sloan Kettering Cancer Center

Investigators

  • Principal Investigator: Jonine Bernstein, PhD, Memorial Sloan Kettering Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT04697927
Other Study ID Numbers:
  • 20-418
First Posted:
Jan 6, 2021
Last Update Posted:
Nov 5, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Memorial Sloan Kettering Cancer Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2021